№ lp_1_2_34516
File format: docx
Character count: 19071
File size: 712 KB
Year:
2023
Region / City:
Scotland
Topic:
Emergency Contraception, Bridging Contraception, Hormonal Contraception
Document Type:
Guidance
Author:
Faculty of Sexual and Reproductive Healthcare
Target Audience:
Community pharmacists, healthcare professionals
Period of validity:
2023-2024
Approval Date:
March 2017, amended July 2023
Date of Changes:
July 2023
Institution:
NHS Scotland
Healthcare Service:
Emergency Contraception, Bridging Contraception
Sexual Health:
Contraception, Pregnancy prevention
Eligibility:
Patients registered with a GP in Scotland, NHS Pharmacy First Scotland users
Conditions:
UKMEC categories, BMI considerations
Guidance:
Clinical, procedural recommendations
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Service Specification No.:
Lot 6
Service:
Provision of Oral Emergency Contraception Services
Authority Lead:
Bernie Brown, Public Health, Derby City Council
Organisation:
Derby City Council
Period:
1 April 2022 – 31 March 2027 (with optional 1+1 year extensions)
Supporting Documentation:
Appendix A Care Pathway; Appendix B Patient Record – hard copy; Appendix C Patient Group Direction (PGD)
Geographical Area:
Derby City
Target Group:
Young women under 25 years of age
Clinical Focus:
Oral Emergency Contraception (Levonorgestrel), Ulipristal Acetate, Cu-IUD, Sexual Health, STI Prevention
Service Setting:
Primary Care
Related Services:
Integrated Sexual Health Service (ISHS); Derbyshire Community Health Services (DCHS)
Policy Framework:
Framework for Sexual Health Improvement in England; Public Health Outcomes Framework
Year:
2023
Country:
Scotland
Region:
Scotland
Subject:
Emergency contraception and bridging contraception
Document type:
Professional guidance
Issuing body:
NHS Scotland
Associated organization:
NHS 24
Note:
Associated organization
Faculty of Sexual and Reproductive Healthcare
Target audience:
Community pharmacists
Medicines referenced:
Ulipristal 30mg (EllaOne®), levonorgestrel, desogestrel
Legal framework:
Patient Group Directions (PGDs)
Geographical applicability:
Scotland
Amendment date:
July 2023
Year:
2025
Region / City:
England
Topic:
Emergency contraception
Document type:
Patient Group Direction (PGD)
Organization / Institution:
NHS England
Author:
Dr Cindy Farmer, Michelle Jenkins, Vicky Garner, Gail Rowley, Julia Hogan, Kate Devonport, Chetna Parmar, Helen Donovan, Carmel Lloyd, Clare Livingstone, Kirsty Armstrong, Dipti Patel, Emma Anderson, Dr Kathy French, Dr Sarah Pillai, Alison Crompton, Andrea Smith, Lisa Knight, Bola Sotubo, Tracy Rogers, Sandra Wolper, Jo Jenkins
Target audience:
Pharmacists, Pharmacy Technicians
Effective period:
June 2025 - February 2026
Approval date:
November 2022
Review date:
September 2025
Expiry date:
February 28, 2026
Year:
2025
Region / city:
United States
Topic:
Emergency Contraception
Document Type:
Clinical Practice Standard
Agency / Organization:
(insert AGENCY name)
Author:
(insert AGENCY name)
Target Audience:
Healthcare providers (MDs, NPs, PAs, DOs, NDs, RNs)
Effective Date:
January 2019
Revised Date:
January 2021, October 2022, January 2025
References:
U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC), U.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR), Contraceptive Technology, 21st Ed
Date of Approval:
Not specified
Date of Changes:
October 2022, January 2025
Year:
2025
Region / City:
England
Topic:
Emergency contraception, NHS Pharmacy Contraception Service
Document Type:
Patient Group Direction
Organization / Institution:
NHS England
Author:
Dr Cindy Farmer, Michelle Jenkins, Vicky Garner, Gail Rowley, Julia Hogan, Kate Devonport, Chetna Parmar, Helen Donovan, Carmel Lloyd, Clare Livingstone, Kirsty Armstrong, Dipti Patel, Emma Anderson, Dr Kathy French, Dr Sarah Pillai, Alison Crompton, Andrea Smith, Lisa Knight, Bola Sotubo, Tracy Rogers, Sandra Wolper, Jo Jenkins
Target Audience:
Community Pharmacists, Pharmacy Technicians
Effective Date:
29 October 2025
Review Date:
September 2028
Expiry Date:
28 February 2029
Approval Date:
November 2022
Document Status:
Draft
Document Version:
1.0
Change History:
Version 1.0 approved on 20 June 2025
Clinical Condition:
Unprotected sexual intercourse, contraceptive failure
Criteria for Inclusion:
Emergency contraception within 96 hours post-UPS, vomiting after EC
Criteria for Exclusion:
Age under 16, pregnancy, recent childbirth or miscarriage
Cautions:
Fraser guidelines for underage assessments, safeguarding protocols
Context:
A PGD outlining the conditions and procedures for emergency contraception administration by authorized pharmacists and technicians in NHS pharmacies in England.
Type of document:
Survey questionnaire
Target population:
Fathers of a new baby
Subject:
Zika virus, pregnancy, mosquito prevention, contraception, paternal involvement
Geographic reference:
Puerto Rico
Administering authority:
CDC/ATSDR Information Collection Review Office
Related program:
PRAMS (Pregnancy Risk Assessment Monitoring System)
Estimated completion time:
15 minutes
Data collection context:
Hospital-based survey
Regulatory reference:
OMB control number requirement
Topics covered:
Zika virus awareness, sexual transmission, microcephaly, mosquito bite prevention, condom use, contraception decision-making, prenatal care participation, employment information
Note:
Year
Theme:
Emergency Hormonal Contraception
Document Type:
Standard Operating Procedure (SOP)
Organization / Institution:
Pharmacy
Target Audience:
Pharmacists, Healthcare Professionals
Guidance:
The Pharmacy First Service for Emergency Hormonal Contraception (EHC)
Purpose:
To describe the process for implementing the Pharmacy First Service for Emergency Hormonal Contraception
Scope:
Provision of Emergency Hormonal Contraception to patients aged 13 and over by registered pharmacists
Year:
2025
Region / City:
England
Subject:
NHS Pharmacy Contraception Service
Document Type:
Master Patient Group Direction (PGD) Sheet
Organization / Institution:
NHS
Author:
N/A
Target Audience:
Registered pharmacists and pharmacy technicians
Period of validity:
29/10/2025 to 28/02/2029
Approval Date:
October 2025
Amendment Date:
N/A
Year:
2003
Region / city:
Maine
Topic:
Emergency Contraception
Document type:
Statutory Law
Agency / Institution:
State of Maine
Author:
State of Maine
Target audience:
Publishers, Legal professionals
Validity period:
Until October 1, 2025
Approval date:
2003
Amendment date:
October 1, 2025
Legal disclaimer:
Required for republication
Context:
Legal text governing the publication and copyright of statutory materials from the State of Maine, with a focus on emergency contraception practice regulations.
Year:
2026
Region / City:
Israel
Topic:
Halacha, Contraception, Jewish Law
Document Type:
Shiur / Lecture Text
Institution:
Yeshivat Har Etzion, Koschitzky Virtual Beit Midrash
Author:
Laurie Novick
Editors:
Rav Ezra Bick, Ilana Elzufon, Shayna Goldberg
Audience:
Adult learners, students of Halacha
Period Covered:
Biblical times to modern contraceptive methods
Date Published:
2026
References:
Bereishit 38:7-10, Yevamot 34b, Nidda 13a, Tosafot Sanhedrin 59b, Tosafot Yevamot 12b, Rosh Ketubot 39a, Masechet Kalla Rabbati 2:7
Legal Focus:
Prohibition of hotza’at zera le-vatala, Hashchatat Zera, permissibility of contraceptive methods according to Halacha
Year:
2023
Region / City:
Lancashire
Theme:
Emergency Hormonal Contraception, Sexual Health
Document Type:
Service Specification
Organization:
Lancashire County Council
Author:
Marie Demaine
Target Audience:
Community Pharmacists, Health Care Professionals, Service Users
Period of Validity:
1st April 2023 – 31st March 2024
Approval Date:
2023-03-31
Modification Date:
N/A
Year:
2026
Region / City:
Chandigarh, India
Subject:
Vaginal contraception, microbiology
Document Type:
Research article
Institution:
Panjab University, Department of Microbiology
Author:
Siftjit Kaur, Vijay Prabha
Target Audience:
Researchers, healthcare professionals
Experimental Model:
Female BALB/c mice
Methodology:
Isolation, characterization, and in-vitro/in-vivo testing of sperm-agglutinating factor (SAF)
Safety Evaluation:
Vaginal epithelium integrity, reproductive performance, systemic toxicity
Number of Published Articles by Author:
111
Contact Email:
[email protected]
Alternative Email:
[email protected]
Phone Number:
+91 9417065675
Year:
2026
Region / city:
United Kingdom / New Zealand
Topic:
Contraception
Document type:
Standing Order
Institution:
Medical Centre or Clinic
Author:
Issuer of standing order
Target audience:
Women over 18 in UK MEC category one
Effective period:
One year from issue date
Issue date:
2026
Review date:
2027
Medication:
Levonorgestrel 150 mcg + ethinylestradiol 30 mcg tablet (Ava 30)
Route of administration:
Oral
Dosage:
One tablet daily
Quantity:
3 months initially, 6 months for continuation
Contraindications:
Patients outside UK MEC category one
Follow-up:
Monitor for contraindications, check BP and weight, verify understanding of the 7-day rule, assess compliance and STD/cervical screening needs
Training requirements:
Registered nurses must be trained and signed off as competent
Supporting documentation:
Healthpathways, Best Practice Journal, UK Medical Eligibility Criteria 2009, New Zealand Formulary, Standing Order Guidelines 2012, Medicines (Standing Order) Regulations 2012
Year:
2023
Region / City:
Scotland
Topic:
Disability Equality, Inclusion, Accessibility
Document Type:
Strategic Plan
Organization:
Disability Equality Scotland
Author:
Lyn Pornaro, Chief Executive Officer
Target Audience:
Disabled People, Policy Makers, Stakeholders
Period of Validity:
2023-2028
Approval Date:
2023
Date of Changes:
N/A
Context:
Strategic Plan for Disability Equality Scotland outlining goals and actions for 2023-2028
Description:
A strategic plan developed by Disability Equality Scotland focusing on advancing equality, inclusion, and participation for disabled people in Scotland.
Year:
2024/25
Region / city:
Not specified
Topic:
Seed corn and Bridging awards
Document type:
Guidance
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Researchers
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Contextual description:
Guidance for applying for Seed corn and Bridging awards to support researchers with career development and funding gaps.
Year:
2026
Region / City:
N/A
Theme:
Religion, Philosophy
Document Type:
Academic Article
Institution:
N/A
Author:
Zia H Shah MD
Target Audience:
Scholars, theologians, spiritual seekers
Period of Validity:
N/A
Approval Date:
N/A
Modification Date:
N/A
Year:
2026
Organization:
Bridging, Inc.
Location:
Bloomington and Roseville, MN, USA
Document Type:
Client Agreement / Instruction Sheet
Target Audience:
Clients receiving furniture donations
Service Fees:
$75 appointment fee, $225 delivery fee
Delivery Window:
8:00 a.m. – 6:00 p.m.
Appointment Duration:
Approximately 1 hour
Virtual Options:
Google Duo, FaceTime, staff-assisted shopping
Safety Requirements:
Clear pathways, no children/pets in delivery area, elevator required for upper floors
Year:
2026
Organisation:
NHS Lothian
Programme:
Clinical Academic Research Pathways Partnership
Funding Scheme:
Pre-Doctoral Bridging Gateway Award
Document Type:
Funding Application Form
Submission Deadline:
16 January 2026
Submission Email:
[email protected]
Eligible Applicants:
NMAHPPS candidates
Sections:
Candidate Details; Research Interests; Research Environment; Support for Application; Referee; Declarations and Signatures
Required Study Leave:
13 days over 6 months
Funding Purpose:
Backfill salary costs to service Cost Centre
Signatories Required:
Applicant; Line Manager; Professional Lead; Finance Contact